According to The Cancer Genome Atlas (TCGA) database, GBM is characterized by aberrant amplification or mutation of EGFR, PDGFRA, CDK4, NF1, HER2, TP53, PIK3R1 and TERT.6, 7. Here, PDGFRA is linked to glioblastoma.